Litigation
Celgene Corp. v. Mylan
dismissed2:19-cv-05802
Patents at issue (1)
Plaintiffs (1)
Defendants (1)
Summary
Identified in the Cigna complaint as Celgene Corp. v. Mylan; opinion at 2020 WL 12570814 (D.N.J. Sept. 25, 2020) granted Mylan's motion to dismiss for improper venue.
Case overview & background
Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Key legal developments & outcome
Major rulings, motions, claim construction, settlements, and the present posture or final disposition.
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Plaintiff representatives
Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).
Defendant representatives
Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).
Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).